NHI Form 4: Insider Exercises 23,000 Shares, Sells 20,765 at $80
Rhea-AI Filing Summary
National Health Investors (NHI) insider filings show option exercises and open-market transactions by Travis David L. The filing reports two acquisitions of 11,666 and 11,334 shares of common stock on 09/23/2025 at a reported price of $69.20 each, and a disposition of 20,765 shares on 09/23/2025 at $80.06 per share. Following the reported non-derivative transactions, the filing lists beneficial ownership totals of 33,221, 44,555, and 23,790 shares in the respective reported lines. The Form 4 also discloses detailed option holdings and exercisable schedules, including multiple tranches with exercise prices ranging from $53.41 to $73.34 and expiration dates through 2030, and shows that several option exercises on 09/23/2025 resulted in zero remaining derivative securities for those specific grants. The report is signed by the reporting person on 09/24/2025.
Positive
- Transparent disclosure of option exercises and share transactions with specific prices and dates
- Detailed option schedule showing exercise prices and expiration dates through 2030, supporting transparency on equity compensation
Negative
- Reported disposition of 20,765 shares at $80.06, indicating insider sale activity
- No company-wide share count or context provided in the filing to assess materiality of these transactions
Insights
TL;DR: Routine insider option exercises and a partial sale; modest net share change, not clearly material to valuation.
The filing documents option exercises that generated acquisitions of 11,666 and 11,334 common shares at $69.20 on 09/23/2025 and a separate disposition of 20,765 shares at $80.06 on the same date. Net share movement from these specific non-derivative transactions is small relative to typical company float sizes; without outstanding company share count or market-impact context in the filing, this appears to be routine executive liquidity and option monetization rather than a material corporate event. The disclosure of extensive option grants across multiple years indicates ongoing equity compensation, with exercise prices from $53.41 to $73.34 and expirations through 2030.
TL;DR: Properly formatted Section 16 report showing exercises and sale; filing timing and signatures are in order.
The Form 4 lists the reporting person as SVP/Chief Accounting Officer and includes a manual signature dated 09/24/2025. Transactions include coded option exercises (M) and a sale (F) on 09/23/2025 with prices disclosed. The mix of acquisitions via exercise and a contemporaneous sale is consistent with routine compliance reporting for compensatory equity and subsequent disposition. The filing contains standard schedules of exercisable option tranches; there are no governance red flags or corrective amendment indicators present within the submitted content.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (Right to buy) 2022 | -- | -- | -- |
| holding | Stock Option (Right to buy) 2022 | -- | -- | -- |
| holding | Stock Option (Right to Buy) 2023 | -- | -- | -- |
| holding | Stock Option (Right to Buy) 2023 | -- | -- | -- |
| holding | Stock Option (Right to Buy) 2023 | -- | -- | -- |
| holding | Stock Option (Right to Buy) 2024 | -- | -- | -- |
| holding | Stock Option (Right to Buy) 2024 | -- | -- | -- |
| holding | Stock Option (Right to Buy) 2024 | -- | -- | -- |
| holding | Stock Option (Right to Buy) 2025 | -- | -- | -- |
| holding | Stock Option (Right to Buy) 2025 | -- | -- | -- |
| holding | Stock Option (Right to Buy) 2025 | -- | -- | -- |
| Exercise | Stock Options (Right to Buy) 2-25-2021 | 11,666 | $0.00 | $0.00 |
| Exercise | Stock Options (Right to Buy) 2-25-2021 | 11,334 | $0.00 | $0.00 |
| Exercise | Common Stock | 11,666 | $69.20 | $807K |
| Exercise | Common Stock | 11,334 | $69.20 | $784K |
| Exercise Price or Tax Liability | Common Stock | 20,765 | $80.06 | $1.66M |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What transactions did Travis David L report on the Form 4 for NHI?
Were option exercises disclosed in the NHI Form 4 and what were the exercise prices?
What beneficial ownership totals are shown after the reported NHI transactions?
Who is the reporting person and what is their role at NHI?
When was the Form 4 signed and filed?
AI-generated analysis. How Rhea-AI works. Not financial advice.
